wire - news in brief


Category

--



Results 51 - 100 of 416.


Health - 16.12.2020
COVID-19 Edition of the Science Barometer Switzerland: People Seek Stronger Voice for Science on Pandemic Issues
COVID-19 Edition of the Science Barometer Switzerland: People Seek Stronger Voice for Science on Pandemic Issues
The people of Switzerland have confirmed their faith in science in the present COVID-19 pandemic. They would like to see scientists contributing their expertise more vigorously to the public and political debate. And most of them believe that political decisions on dealing with the pandemic should be based on scientific findings and foundations.

Pharmacology - Health - 16.12.2020
Novartis investigational oral therapy iptacopan (LNP023) receives FDA Breakthrough Therapy Designation for PNH and Rare Pediatric Disease Designation for C3G
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare and life-threatening blood disorder, resulting in debilitating symptoms that can impact patients' quality of life 1-3 C3 glomerulopathy (C3G) is a

Pharmacology - Health - 16.12.2020
Novartis announces positive FDA Advisory Committee recommendation for use of Entresto to treat patients with HFpEF
The Committee voted 12 to 1 that the data presented support the use of Entresto in treatment of patients with heart failure with preserved ejection fraction (HFpEF) Potential Q1 2021 sNDA approval co

Environment - Innovation - 15.12.2020
Download, print and save the reef!
Download, print and save the reef!
Coral reefs are in acute danger of disappearing due to climate change. An artist and a marine biologist have taken up the challenge of rebuilding the reefs by harnessing the power of 3D printers.

Economics / Business - Career - 15.12.2020

Environment - Economics / Business - 15.12.2020

Health - Pharmacology - 15.12.2020
New synthetic molecule can kill the flu virus
New synthetic molecule can kill the flu virus
Scientists have developed a synthetic molecule capable of killing the virus that causes influenza. They hope their discovery will lead to an effective drug treatment.

Pharmacology - Health - 15.12.2020
Novartis reports positive topline results from second Phase III trial of Beovu in patients with diabetic macular edema
In Phase III KESTREL study, Beovu (brolucizumab 6 mg) achieved its primary endpoint of non-inferiority to aflibercept 2 mg in change in best-corrected visual acuity (BCVA) at year one (week 52) 1 In

Environment - Politics - 15.12.2020
"The key thing is to make a start."
Civil society and governments struggle to take action when it comes to climate change. So what's the solution? We asked climate researcher Reto Knutti and climate strike advocate Marie-Claire Graf for their perspectives.

Health - Social Sciences - 14.12.2020

Health - Campus - 14.12.2020
Ticino Scienza, the news portal to "explain excellence"
Over the past two decades the Italian-speaking part of Switzerland has witnessed a strong rise in scientific research activities, both in the private and the public sector.

Psychology - Pedagogy - 14.12.2020
Using play to “school” children's emotions
Using play to “school” children’s emotions
Pretend play promotes the development of socio-emotional competences in children aged five and six. Being socially and emotionally competent from an early age is likely to help children win acceptance by their peers, build better relationships with teachers, and facilitate academic learning.

Environment - 14.12.2020
University of Bern wants to be climate-neutral by 2025
University of Bern wants to be climate-neutral by 2025
The University of Bern has set itself the goal of becoming a climate-neutral institution by 2025 in all areas in which it has a direct influence.

Criminology / Forensics - Law - 14.12.2020
Can we "repair" criminal justice?
Passing a law, committing a crime, inflicting a sanction. These are the main the stages of criminal justice at the heart of modern legal systems.

Environment - Physics - 14.12.2020
Foundations for the energy system of tomorrow
On the road to a sustainable energy system, technologies for the flexible conversion and efficient storage of energy are becoming increasingly important.

Health - Administration - 11.12.2020
"Hardly anyone had anticipated this scenario"
The COVID-19 pandemic is putting Swiss crisis management to the test. ETH Professor Andreas Wenger and his team from the Center for Security Studies have investigated in detail how well Switzerland coped with the first phase of the crisis.

Health - Innovation - 11.12.2020

Health - Computer Science - 11.12.2020
Augmented reality in surgery
Augmented reality in surgery
A team at Balgrist University Hospital successfully completed the first holographically navigated spine surgery.

Life Sciences - Environment - 11.12.2020

Health - Pharmacology - 11.12.2020
Roche launches laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients
The Elecsys SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in the diagnosis of active SARS-CoV-2 infection Roche will be able to ramp up to a double-digit million number

Innovation - Computer Science - 10.12.2020
Engineering at the service of humanitarian aid
Engineering at the service of humanitarian aid
The Engineering Humanitarian Aid initiative, officially launched on 10 December 2020, will harness the expertise of Switzerland's two federal institutes of technology to benefit humanitarian aid programs.

Innovation - Computer Science - 10.12.2020
EPFL, ETH Zurich and the ICRC team up to bolster humanitarian aid
EPFL, ETH Zurich and the ICRC team up to bolster humanitarian aid
The Engineering Humanitarian Aid initiative, officially launched on 10 December 2020, will harness the expertise of Switzerland's two federal institutes of technology to benefit humanitarian aid programs.

Health - Psychology - 10.12.2020
Prioritizing Mental Health during the COVID-19 Pandemic
Prioritizing Mental Health during the COVID-19 Pandemic
The coronavirus is not only a risk for our physical health, but also affects our mental health and emotional well-being.

Health - Pharmacology - 09.12.2020
Novartis Kisqali demonstrates nearly five years median overall survival in metastatic breast cancer
MONALEESA-7 median overall survival (OS) results reinforce Kisqali as the CDK4/6 inhibitor with un rivaled OS evidence 1 Kisqali plus endocrine therapy had a median OS of nearly five years (58&peri

Computer Science - Art and Design - 09.12.2020
ETH app brings the Graphische Sammlung's artwork to life
ETH app brings the Graphische Sammlung’s artwork to life
The Graphische Sammlung opened a new exhibition on 9 December. What makes this latest exhibition special is its integration with an augmented reality app for mobile phones and tablets, which allows visitors to interact with the artwork on display.

Health - Pharmacology - 09.12.2020
Roche partners with Moderna to include SARS-CoV-2 antibody test in ongoing COVID-19 vaccine trials
Moderna's vaccine triggers an antibody response to the SARS-CoV-2 spike protein The Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in vaccine tri

Research Management - Pharmacology - 09.12.2020

Pharmacology - Health - 08.12.2020
Novartis investigational STAMP inhibitor asciminib (ABL001) shows superior MMR rate to Bosulif * in chronic myeloid leukemia trial
At 24 weeks, asciminib nearly doubled the major molecular response (MMR) rate compared to Bosulif (bosutinib)*, in patients resistant to, or intolerant of, at least two prior tyrosine kinase inhibito

Health - 08.12.2020
COVID-19: persistent symptoms in one third of cases
Physicians in Geneva have shown that some of the troublesome symptoms of COVID-19 could last more than 6 weeks, even in patients without underlying risk factors.

Pharmacology - Health - 08.12.2020
Roche presents new data from its bispecific antibody portfolio across a range of blood cancers
Latest data to be presented at ASH 2020 includes results in non-Hodgkin lymphoma and heavily pre-treated multiple myeloma Portfolio includes two CD20xCD3 bispecifics, mosunetuzumab and glofitamab, an

Pedagogy - 07.12.2020

Career - Life Sciences - 07.12.2020

Linguistics / Literature - 07.12.2020

Pharmacology - Health - 05.12.2020
Novartis analyses confirm benefit of Kymriah with clinically meaningful rates of complete response seen in patients with certain advanced lymphomas
Interim analysis from the investigational ELARA study shows, 65% of patients with r/r follicular lymphoma evaluated for efficacy achieved a complete response and the overall response rate was 83% 1 L

Pharmacology - Health - 04.12.2020
Novartis announces first data from REACH3 trial showing Jakavi (ruxolitinib) significantly improved outcomes in patients with steroid-resistant/dependent chronic GvHD
Results of REACH3 trial also demonstrate significant improvements in failure-free survival (FFS) and patient-reported symptoms 1 Chronic graft-versus-host disease (GvHD) is a life-threatening complic

Health - Economics / Business - 04.12.2020
Swiss TPH Symposium: Reshaping Healthcare Supply Chains
Swiss TPH Symposium: Reshaping Healthcare Supply Chains
Strong and resilient supply chains ensure the provision of quality health products and vaccines to patients, making them a central component of health systems.